Crossref
Rituximab in Severe Mucocutaneous Pemphigus Vulgaris Complicated by Sepsis: a Difficult Path to Disease Control
Dermatology Review · 2026 · 113 (2) · 102-106
DOI: 10.5114/dr.2026.163240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology Review, 2026. Verfasst von Anna Wojas-Pelc und 5 weiteren Autor:innen.
Themen: Sepsis
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wojas-Pelc, A., Brzozowska, M., Kozłowska, A., Hałubiec, P., Obtułowicz, B., & Jaworek, A. K. (2026). Rituximab in Severe Mucocutaneous Pemphigus Vulgaris Complicated by Sepsis: a Difficult Path to Disease Control. Dermatology Review, 113(2), 102-106. https://doi.org/10.5114/dr.2026.163240
Vancouver
Wojas-Pelc A, Brzozowska M, Kozłowska A, Hałubiec P, Obtułowicz B, Jaworek AK. Rituximab in Severe Mucocutaneous Pemphigus Vulgaris Complicated by Sepsis: a Difficult Path to Disease Control. Dermatology Review. 2026;113(2):102-106. doi:10.5114/dr.2026.163240
BibTeX
@article{WojasPelc2026,
author = {Wojas-Pelc, Anna and Brzozowska, Mirella and Kozłowska, Arletta and Hałubiec, Przemysław and Obtułowicz, Bartosz and Jaworek, Andrzej K.},
title = {Rituximab in Severe Mucocutaneous Pemphigus Vulgaris Complicated by Sepsis: a Difficult Path to Disease Control},
journal = {Dermatology Review},
year = {2026},
volume = {113},
number = {2},
pages = {102--106},
doi = {10.5114/dr.2026.163240}
}
EUVIMED